133 related articles for article (PubMed ID: 9738778)
1. Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma.
Peterson SR; Talpur R; Duvic M
J Am Acad Dermatol; 1998 Sep; 39(3):434-8. PubMed ID: 9738778
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma presenting as mycosis fungoides with a T-/null-cell phenotype: report of two cases.
Bekel L; Chaby G; Lok C; Dadban A; Chatelain D; Ingen-Housz-Oro S; Ortonne N
Br J Dermatol; 2015 Jun; 172(6):1637-1641. PubMed ID: 25420682
[TBL] [Abstract][Full Text] [Related]
4. Infantile-onset cutaneous T-cell lymphoma.
Tsianakas A; Kienast AK; Hoeger PH
Br J Dermatol; 2008 Dec; 159(6):1338-41. PubMed ID: 18717674
[TBL] [Abstract][Full Text] [Related]
5. Chronic cutaneous lupus erythematosus mimicking mycosis fungoides.
Friss AB; Cohen PR; Bruce S; Duvic M
J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):891-5. PubMed ID: 7593804
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
Wong HK
G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
[TBL] [Abstract][Full Text] [Related]
8. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency.
Gammon B; Robson A; Deonizio J; Arkin L; Guitart J
J Am Acad Dermatol; 2014 Sep; 71(3):555-60. PubMed ID: 24813299
[TBL] [Abstract][Full Text] [Related]
9. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
10. Necrobiotic cutaneous T-cell lymphoma.
Woollons A; Darvay A; Khorshid SM; Whittaker S; Jones RR
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):815-9. PubMed ID: 10534657
[TBL] [Abstract][Full Text] [Related]
11. Granulomatous slack skin disease: a review, in comparison with mycosis fungoides.
Shah A; Safaya A
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1472-8. PubMed ID: 22435618
[TBL] [Abstract][Full Text] [Related]
12. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
[TBL] [Abstract][Full Text] [Related]
13. Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.
Marks E; Shi Y; Wang Y
Virchows Arch; 2019 Nov; 475(5):637-648. PubMed ID: 31218405
[TBL] [Abstract][Full Text] [Related]
14. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
17. A new nail in the CTCL coffin.
Lessin SR
J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic.
Chang MB; Weaver AL; Brewer JD
Int J Dermatol; 2014 Aug; 53(8):966-70. PubMed ID: 24134412
[TBL] [Abstract][Full Text] [Related]
19. T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.
Humme D; Lukowsky A; Gierisch M; Haider A; Vandersee S; Assaf C; Sterry W; Möbs M; Beyer M
Exp Dermatol; 2014 Jul; 23(7):504-8. PubMed ID: 24862432
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
